Quoin Pharmaceuticals Provides Corporate Update And Reports First Quarter 2026 Financial Results

(MENAFN - GlobeNewsWire - Nasdaq) – Filed Breakthrough Medicine Designation Application with Saudi FDA for QRX003 in Netherton Syndrome – Submitted Application to Japanese MHLW for Orphan Drug ...